Jonathan Aschoff
Stock Analyst at Roth MKM
(0.03)
# 4,788
Out of 5,055 analysts
441
Total ratings
29.1%
Success rate
-22%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTHI NeOnc Technologies Holdings | Initiated Coverage: Buy | $20 | $2.66 | +651.88% | 1 | Sep 24, 2026 | |
| MDCX Medicus Pharma | Reiterated: Buy | $9 | $3.12 | +188.46% | 5 | Sep 9, 2026 | |
| APVO Aptevo Therapeutics | Reiterated: Buy | $21 | $1.73 | +1,113.87% | 12 | Sep 3, 2026 | |
| CELZ Creative Medical Technology Holdings | Reiterated: Buy | $20 | $0.7723 | +2,489.67% | 9 | Aug 20, 2026 | |
| CLNN Clene | Reiterated: Buy | $30 | $3.31 | +806.34% | 7 | Aug 17, 2026 | |
| GTBP GT Biopharma | Reiterated: Buy | $3 | $6.21 | -51.69% | 6 | Aug 17, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $30 → $5 | $1.54 | +225.73% | 8 | Aug 10, 2026 | |
| REVB Revelation Biosciences | Reiterated: Buy | $16 | $0.7197 | +2,123.15% | 14 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $21 | $10.23 | +105.28% | 18 | Aug 6, 2026 | |
| MBRX Moleculin Biotech | Reiterated: Buy | $31 | $0.411 | +7,442.58% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $33 | $18.03 | +83.03% | 3 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.2413 | +4,044.22% | 15 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.83 | +984.34% | 12 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $20.25 | +171.60% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $11 | $1.18 | +832.20% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $15 | $1.50 | +900.00% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.0001 | n/a | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $2 | $0.0006 | n/a | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $0.53 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €2.57 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.8945 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.60 | $0.03 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $4.25 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $36 | $34.24 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $24 | $2.22 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $620 → $500 | $0.003 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $8.51 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.8412 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.11 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.0001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.000001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $7.84 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.0001 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $0.986 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.09 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $26 | $1.60 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.5382 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.066 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.48 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.362 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $162.22 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $3.09 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $111.57 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $0.702 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $27.84 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $7.66 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $3.94 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $54.37 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $36.40 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $36.89 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $778.36 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3407 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $1.17 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $55.14 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $540.03 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.04 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.53 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $116.82 | n/a | 2 | Apr 16, 2012 |
NeOnc Technologies Holdings
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $2.66
Upside: +651.88%
Medicus Pharma
Sep 9, 2026
Reiterated: Buy
Price Target: $9
Current: $3.12
Upside: +188.46%
Aptevo Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $21
Current: $1.73
Upside: +1,113.87%
Creative Medical Technology Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $20
Current: $0.7723
Upside: +2,489.67%
Clene
Aug 17, 2026
Reiterated: Buy
Price Target: $30
Current: $3.31
Upside: +806.34%
GT Biopharma
Aug 17, 2026
Reiterated: Buy
Price Target: $3
Current: $6.21
Upside: -51.69%
Tenax Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $30 → $5
Current: $1.54
Upside: +225.73%
Revelation Biosciences
Aug 7, 2026
Reiterated: Buy
Price Target: $16
Current: $0.7197
Upside: +2,123.15%
Zevra Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $21
Current: $10.23
Upside: +105.28%
Moleculin Biotech
Aug 4, 2026
Reiterated: Buy
Price Target: $31
Current: $0.411
Upside: +7,442.58%
Jul 6, 2026
Rated: Buy
Price Target: $20 → $33
Current: $18.03
Upside: +83.03%
May 26, 2026
Reiterated: Buy
Price Target: $10
Current: $0.2413
Upside: +4,044.22%
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $0.83
Upside: +984.34%
May 15, 2026
Reiterated: Buy
Price Target: $55
Current: $20.25
Upside: +171.60%
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $1.18
Upside: +832.20%
Apr 2, 2026
Reiterated: Buy
Price Target: $18 → $15
Current: $1.50
Upside: +900.00%
Jul 8, 2025
Reiterated: Buy
Price Target: $4 → $3
Current: $0.0001
Upside: n/a
Jun 4, 2025
Reiterated: Buy
Price Target: $9 → $2
Current: $0.0006
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $13 → $11
Current: $0.53
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: €12.00
Current: €2.57
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.8945
Upside: n/a
Sep 3, 2024
Reiterated: Buy
Price Target: $0.60
Current: $0.03
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $4.25
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $25 → $36
Current: $34.24
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: $250 → $24
Current: $2.22
Upside: n/a
Dec 18, 2023
Reiterated: Buy
Price Target: $620 → $500
Current: $0.003
Upside: n/a
Feb 27, 2023
Reiterated: Buy
Price Target: $14
Current: $8.51
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $0.8412
Upside: n/a
Apr 28, 2022
Reiterated: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.11
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.0001
Upside: n/a
Aug 30, 2021
Reiterated: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $7.84
Upside: n/a
Nov 22, 2020
Reiterated: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $0.986
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $3.09
Upside: n/a
Jul 14, 2020
Reiterated: Buy
Price Target: $13 → $26
Current: $1.60
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.5382
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.066
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $1.48
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.362
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $162.22
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $3.09
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $111.57
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $0.702
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $27.84
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $7.66
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $3.94
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $54.37
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $36.40
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $36.89
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $778.36
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.3407
Upside: n/a
Dec 8, 2014
Reiterated: Buy
Price Target: $16
Current: $1.17
Upside: n/a
Oct 24, 2014
Reiterated: Hold
Price Target: n/a
Current: $55.14
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $540.03
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $1.04
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $20.53
Upside: n/a
Apr 16, 2012
Reiterated: Buy
Price Target: $13 → $11
Current: $116.82
Upside: n/a